News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,488 Results
Type
Article (2492)
Company Profile (22)
Press Release (102974)
Section
Business (43426)
Career Advice (66)
Deals (6790)
Drug Delivery (4)
Drug Development (12561)
Employer Resources (9)
FDA (2191)
Job Trends (2279)
News (62701)
Policy (3638)
Tag
Academia (226)
Accelerated approval (3)
Allergies (20)
Alliances (4858)
ALS (12)
Alzheimer's disease (190)
Antibody-drug conjugate (ADC) (23)
Approvals (2244)
Artificial intelligence (27)
Autoimmune disease (4)
Automation (1)
Bankruptcy (29)
Best Places to Work (2178)
Biosimilars (12)
Biotechnology (17)
Bladder cancer (34)
Brain cancer (2)
Breast cancer (78)
Cancer (510)
Cardiovascular disease (33)
Career advice (61)
Career pathing (3)
CAR-T (18)
Cell therapy (59)
Cervical cancer (6)
Clinical research (10986)
Collaboration (95)
Compensation (49)
Complete response letters (1)
COVID-19 (207)
CRISPR (5)
C-suite (11)
Cystic fibrosis (8)
Data (545)
Depression (3)
Diabetes (37)
Diagnostics (1149)
Digital health (3)
Diversity (1)
Drug discovery (9)
Drug pricing (2)
Drug shortages (5)
Duchenne muscular dystrophy (13)
Earnings (35108)
Employer branding (1)
Employer resources (6)
Events (14567)
Executive appointments (40)
FDA (2490)
Frontotemporal dementia (2)
Funding (97)
Gene editing (11)
Generative AI (4)
Gene therapy (34)
GLP-1 (96)
Government (351)
Guidances (112)
Healthcare (3011)
Huntington's disease (2)
IgA nephropathy (6)
Immunology and inflammation (22)
Indications (6)
Infectious disease (217)
Inflammatory bowel disease (19)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (16)
Interviews (7)
IPO (4893)
IRA (1)
Job creations (254)
Job search strategy (54)
Kidney cancer (2)
Labor market (6)
Layoffs (44)
Legal (613)
Liver cancer (16)
Lung cancer (78)
Lymphoma (42)
Management (2)
Manufacturing (36)
MASH (23)
Medical device (2656)
Medtech (2657)
Mergers & acquisitions (1981)
Metabolic disorders (116)
Multiple sclerosis (22)
NASH (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (2)
Neuroscience (283)
NextGen: Class of 2025 (736)
Non-profit (410)
Now hiring (1)
Obesity (55)
Opinion (6)
Ovarian cancer (24)
Pain (14)
Pancreatic cancer (18)
Parkinson's disease (22)
Partnered (2)
Patents (28)
Patient recruitment (8)
Peanut (12)
People (4315)
Pharmaceutical (11)
Pharmacy benefit managers (3)
Phase I (2952)
Phase II (4606)
Phase III (4254)
Pipeline (634)
Policy (4)
Postmarket research (359)
Preclinical (1005)
Press Release (1)
Prostate cancer (24)
Radiopharmaceuticals (30)
Rare diseases (40)
Real estate (402)
Recruiting (5)
Regulatory (2960)
Reports (9)
Research institute (226)
Resumes & cover letters (6)
Rett syndrome (2)
RSV (4)
Schizophrenia (16)
Series A (19)
Series B (8)
Service/supplier (1)
Sickle cell disease (3)
Special edition (2)
Spinal muscular atrophy (32)
Sponsored (3)
Startups (268)
Stomach cancer (2)
Supply chain (9)
Tariffs (2)
The Weekly (3)
Vaccines (77)
Venture capitalists (3)
Weight loss (36)
Women's health (3)
Worklife (2)
Date
Today (57)
Last 7 days (321)
Last 30 days (748)
Last 365 days (6534)
2025 (2444)
2024 (7064)
2023 (8291)
2022 (10050)
2021 (11405)
2020 (10139)
2019 (7112)
2018 (5614)
2017 (5399)
2016 (3985)
2015 (5268)
2014 (3644)
2013 (2217)
2012 (2442)
2011 (3011)
2010 (2549)
Location
Africa (60)
Alabama (6)
Alaska (2)
Arizona (36)
Arkansas (1)
Asia (5040)
Australia (1341)
California (1299)
Canada (490)
China (88)
Colorado (51)
Connecticut (56)
Delaware (46)
Europe (14677)
Florida (172)
Georgia (40)
Idaho (5)
Illinois (78)
India (4)
Indiana (77)
Japan (41)
Kansas (17)
Kentucky (3)
Louisiana (7)
Maine (35)
Maryland (186)
Massachusetts (877)
Michigan (43)
Minnesota (95)
Missouri (10)
Montana (4)
Nebraska (1)
Nevada (18)
New Hampshire (13)
New Jersey (355)
New York (365)
North Carolina (142)
North Dakota (1)
Northern California (630)
Ohio (28)
Oregon (1)
Pennsylvania (341)
Puerto Rico (8)
South America (126)
South Carolina (1)
Southern California (511)
Tennessee (18)
Texas (134)
United States (4610)
Utah (36)
Virginia (20)
Washington D.C. (3)
Washington State (111)
Wisconsin (6)
105,488 Results for "41".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
April 28, 2025
·
1 min read
Press Releases
Moderna to Present at Upcoming Bernstein’s 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
May 8, 2025
·
1 min read
Press Releases
Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
April 29, 2025
·
3 min read
Press Releases
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
April 22, 2025
·
4 min read
Press Releases
Cell-based Assays Market Size to Surpass USD 41.1 Billion by 2034
February 6, 2025
·
1 min read
Press Releases
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy
March 19, 2025
·
9 min read
Press Releases
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B
February 26, 2025
·
6 min read
Drug Development
Novo Nordisk Continues Manufacturing Spending Spree With $4.1B Investment
Novo Nordisk on Monday announced it is boosting its manufacturing capabilities with a $4.1 billion commitment to construct a second fill and finishing facility in Clayton, North Carolina.
June 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
April 9, 2025
·
4 min read
Press Releases
Proliferative Vitreoretinopathy Market Size to Reach USD 4.1 Billion by 2035, Impelled by Increased Investment in Ophthalmology and Healthcare Infrastructure
February 19, 2025
·
11 min read
1 of 10,549
Next
